戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 t of biologically active natural product (-)-laulimalide.
2 enced in creation of fully active analogs of laulimalide.
3  of peloruside A on the crystal structure of laulimalide.
4 red from the effects of either paclitaxel or laulimalide.
5 r to have a mechanism of action identical to laulimalide.
6 o retain the unique biological activities of laulimalide.
7 , including the anticancer marine polyketide laulimalide.
8 An enantioselective first total synthesis of laulimalide (1) is described.
9                                              Laulimalide, a natural product from marine sponges, is a
10                                              Laulimalide, a remarkably potent antitumor macrolide, ha
11                 Previous work has shown that laulimalide, a sponge-derived natural product, resembles
12                        We also report that a laulimalide analogue lacking the epoxide moiety, while l
13 istant cell lines were less resistant to the laulimalide analogues.
14 most potent analogues, C(16)-C(17)-des-epoxy laulimalide and C(20)-methoxy laulimalide, appear to hav
15                               When combined, laulimalide and docetaxel (Taxotere) synergistically inh
16 he most dramatic difference observed between laulimalide and epothilone A was that only laulimalide w
17 paclitaxel and that the polymers formed with laulimalide and epothilone A were more stable at 0 degre
18              In contrast to paclitaxel, both laulimalide and isolaulimalide inhibited the proliferati
19                                              Laulimalide and isolaulimalide represent a new class of
20 otubule agents from natural products yielded laulimalide and isolaulimalide, two compounds with pacli
21            Because stoichiometric amounts of laulimalide and paclitaxel can cause extensive tubulin a
22  microtubules formed in the presence of both laulimalide and paclitaxel contained near-molar quantiti
23 t study, we searched for differences between laulimalide and paclitaxel in their interactions with tu
24         Nearly equimolar amounts of tubulin, laulimalide, and paclitaxel are recovered from microtubu
25  of epothilone B, ixabepilone (IXEMPRA(TM)), laulimalide, and peloruside A on CET conformation.
26 (17)-des-epoxy laulimalide and C(20)-methoxy laulimalide, appear to have a mechanism of action identi
27                          We report here that laulimalide binds at a site on tubulin polymer that is d
28 the uncharacterized biosynthetic pathway for laulimalide can be confidently postulated, the biosynthe
29           In this way, we have identified 15 laulimalide conformations that can be classified into 5
30     The C(16)-C(17)-des-epoxy, C(20)-methoxy laulimalide derivative, which incorporates both chemical
31                     In summary, analogues of laulimalide designed to minimize or eliminate its intrin
32 arly strongly stabilized by peloruside A and laulimalide, drugs that bind outside the taxane site.
33                                              Laulimalide exhibits an activity profile different from
34                        Similar to docetaxel, laulimalide had no effect on the VEGF-induced tyrosine p
35 anolides A (1) and B (2), isolaulimalide and laulimalide, have taxol-like microtubule-stabilizing act
36 g the epoxide moiety, while less active than laulimalide in biochemical and cellular systems, is prob
37 rformed an NAMFIS deconvolution analysis for laulimalide in DMSO-d6.
38 logues initiated cellular changes similar to laulimalide, including increased density of interphase m
39                                              Laulimalide-induced assembly, like paclitaxel-induced as
40 ed paclitaxel-induced polymers, although the laulimalide-induced polymers appeared notably longer.
41                                              Laulimalide-induced tubulin polymers resembled paclitaxe
42 oruside A was significantly less active than laulimalide, inducing assembly in a manner that was most
43          In the present study, we found that laulimalide inhibited human umbilical vein endothelial c
44                                              Laulimalide inhibited integrin activation; however, comp
45   In conclusion, although both docetaxel and laulimalide inhibited integrin-associated signaling path
46               Possible mechanism(s) by which laulimalide inhibited VEGF-induced HUVEC migration were
47                                              Laulimalide is a cytotoxic natural product that stabiliz
48                                              Laulimalide is a potent inhibitor of cellular proliferat
49                                              Laulimalide is a potent, structurally unique microtubule
50                                              Laulimalide is a structurally unique 20-membered marine
51                                              Laulimalide is also active in P-glycoprotein overexpress
52 thesis of the potent antitumor macrolide (-)-laulimalide is described.
53                                              Laulimalide is one of the newest naturally occurring mac
54  The compound enhances tubulin assembly, and laulimalide is quantitatively comparable to paclitaxel i
55                     Compared with docetaxel, laulimalide more potently caused a reduction in the cons
56 is present in a reaction mixture with either laulimalide or paclitaxel, nucleotide hydrolysis occurs
57 e displaced from microtubules by paclitaxel, laulimalide, or denaturing conditions, suggesting irreve
58 ular oxa-conjugate addition in a macrocyclic laulimalide precursor could be the origin of the 2,6-dih
59                                              Laulimalide represents a new class of antitumor agents w
60                 Treatment of A-10 cells with laulimalide resulted in a dose-dependent reorganization
61          Incubation of MDA-MB-435 cells with laulimalide resulted in mitotic arrest and activation of
62               We found that peloruside A and laulimalide showed no synergism but that both compounds
63  The apparent binding of peloruside A in the laulimalide site led us to attempt construction of a pha
64 ymers suggest that peloruside A binds in the laulimalide site, which is distinct from the taxoid site
65                                              Laulimalide stimulated tubulin polymerization and, altho
66                        Low concentrations of laulimalide substantially blocked subsequent VEGFR-2 dow
67  effects between AJ and either paclitaxel or laulimalide, suggest a distinct binding site.
68 uild the macrocycle enabled us to synthesize laulimalide via an efficient and convergent pathway.
69 n laulimalide and epothilone A was that only laulimalide was able to enhance assembly synergistically
70                                              Laulimalide was active against cell lines resistant to p
71                                              Laulimalide was compared with paclitaxel and epothilone
72  the only compound that mimics the action of laulimalide, we examined combinations of microtubule-sta
73 examine the conformational energy surface of laulimalide, we have performed an NAMFIS deconvolution a
74                            Five analogues of laulimalide were designed to exhibit enhanced chemical s
75                                We found that laulimalide, while as active as paclitaxel, epothilone A
76 he role of the epoxide in the interaction of laulimalide with tubulin is therefore justified.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。